Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jagannadha K Sastry"'
Autor:
Olsi Gjyshi, Adam Grippin, Lauren Andring, Anuja Jhingran, Lilie L. Lin, Julianna Bronk, Patricia J. Eifel, Melissa M. Joyner, Jagannadha K. Sastry, Kyoko Yoshida-Court, Travis N. Solley, Tatiana Cisneros Napravnik, Madison P. O'Hara, Venkatesh L Hegde, Lauren E. Colbert, Ann H Klopp
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100578- (2023)
Purpose: The immune system’s role in mediating the cytotoxic effects of chemoradiotherapy remains not completely understood. The integration of immunotherapies into treatment will require insight into features and timing of the immune microenvironm
Externí odkaz:
https://doaj.org/article/7f3ed66fbc544424af486805649d57a8
Autor:
Peiying Yang PhD, Patrea R. Rhea BS, Tara Conway BS, Sita Nookala BS, Venkatesh Hegde PhD, Mihai Gagea DVSc, Nadim J. Ajami PhD, Sean L. Harribance, Jewel Ochoa MA, Jagannadha K. Sastry PhD, Lorenzo Cohen PhD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Studies have demonstrated that purported biofield therapy emitted from humans can inhibit the proliferation of cancer cells and suppress tumor growth in various cancers. We explored the effects of biofield therapy on tumor growth in the Lewis lung ca
Externí odkaz:
https://doaj.org/article/63c79d4c9cfa463680f2bef60e089416
Autor:
Kyoko Yoshida-Court, Olsi Gjyshi, Madison O’Hara, Lilie Lin, Anuja Jhingran, Melissa Joyner, Tatiana Cisneros Napravnik, Erica Lynn, Lauren Colbert, Jagannadha K Sastry, Ann Klopp
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::348fcc255c946a6632817f6d44001932
https://doi.org/10.1136/jitc-2022-sitc2022.0674
https://doi.org/10.1136/jitc-2022-sitc2022.0674
Autor:
Vipul K. Singh, Eric Chau, Abhishek Mishra, Alexandro DeAnda, Venkatesh L. Hegde, Jagannadha K. Sastry, David Haviland, Chinnaswamy Jagannath, Biana Godin, Arshad Khan
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 349
We describe a role of CD44-mediated signaling during host-defense against tuberculosis (TB) using a mouse model of TB and studies in M. tuberculosis (Mtb) infected human macrophage (MФ). Liposomes targeting CD44 using thioaptamers (CD44TA-LIP) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75429dadb5b213147d76300580a84e4c
https://pubmed.ncbi.nlm.nih.gov/35914613
https://pubmed.ncbi.nlm.nih.gov/35914613
Autor:
Soung Chul Cha, Larry W. Kwak, Bharti P. Nehete, Stephanie J. Buchl, Jagannadha K. Sastry, Pramod N. Nehete, Hong Qin, Hong He
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2020 (2020)
BioMed Research International, Vol 2020 (2020)
HIV vaccine candidates with improved immunogenicity and induction of mucosal T-cell immunity are needed. A prime-boost strategy using a novel HIV glycoprotein 120 DNA vaccine was employed to immunize rhesus macaques. The DNA vaccine encoded a chimeri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53f4b70a65b5ec06d0252be0b8137d8c
http://europepmc.org/articles/PMC7648672
http://europepmc.org/articles/PMC7648672
Autor:
Lauren E. Colbert, Jagannadha K. Sastry, Stephanie Dorta-Estremera, Ann H. Klopp, Andrea Delgado, Sita Nookala, Ananta V. Yanamandra, Guojun Yang, Lin L. Lilie, Patricia J. Eifel, Anuja Jhingran, Megan Mikkelson, James W. Welsh, Kathleen M. Schmeler
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:593-600
Purpose Radiation therapy has direct cytotoxic effects on tumor-infiltrating lymphocytes, but it also has immune stimulatory effects that increase immune cell infiltration. The dynamics of these competing effects on immune cells at the site of the tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5c1f047c65e444645e8fb82ef737aea
https://doi.org/10.1016/j.ijrobp.2018.06.404
https://doi.org/10.1016/j.ijrobp.2018.06.404
Autor:
Manas Gupte, R. Lyle Hood, Marco Folci, Nicola Di Trani, Antonia Susnjar, Roberto C. Arduino, Peter L. Anderson, Pramod N. Nehete, Priya Jain, Lane R. Bushman, Giacomo Bruno, Carly S. Filgueira, Ming Hu, Alessandro Grattoni, Corrine Ying Xuan Chua, Song Gao, Kathryn A. Shelton, Andrea Ballerini, Jagannadha K. Sastry, Mark A. Marzinke
Publikováno v:
Journal of Controlled Release. 286:315-325
Pre-exposure prophylaxis (PrEP) with antiretroviral (ARV) drugs are effective at preventing human immunodeficiency virus (HIV) transmission. However, implementation of PrEP presents significant challenges due to poor user adherence, low accessibility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a9733433c5116eb52e8117fce3ab977
https://doi.org/10.1016/j.jconrel.2018.08.010
https://doi.org/10.1016/j.jconrel.2018.08.010
Autor:
Stephanie S. Anguiano-Zarate, William E. Matchett, Pramod N. Nehete, Jagannadha K. Sastry, Michael A. Barry, Andrea Marzi
Publikováno v:
The Journal of Infectious Diseases. 218:1883-1889
Recent West African Ebola virus (EBOV) epidemics have led to testing different anti-EBOV vaccines, including a replication-defective adenovirus (RD-Ad) vector (ChAd3-EBOV) and an infectious, replication-competent recombinant vesicular stomatitis viru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::098504e15da9ff2705dc09446e29b2ee
https://doi.org/10.1093/infdis/jiy411
https://doi.org/10.1093/infdis/jiy411
Autor:
Edwin Roger Parra Cuentas, Ravaen B Slay, Qianyun Luo, Ryan P. Goepfert, Diana Bell, Michelle A. Williams, Minghao Dang, Keiko Akagi, Kathrina Marcelo, Alexandre Reuben, Weihong Xiao, Michael A. Curran, Joseph Fresquez, Bo Jiang, Jagannadha K. Sastry, Pragya Sinha, Venkatesh Hegde, Linghua Wang, Ananta V. Yanamandra, Neil D. Gross, Amit Agrawal, Xiuning Le, Jeffrey N. Myers, Maura L. Gillison, Stephen Y. Lai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundHuman papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HPV+ HNSCC) is a disease that has moderate response to anti-PD-1/L1 immune checkpoint blockade, with the response rates less than 20% and median progression-free sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22f979d55262a3b52dc2a779a70d88f
https://doi.org/10.1136/jitc-2021-sitc2021.754
https://doi.org/10.1136/jitc-2021-sitc2021.754
Autor:
Venkatesh L Hegde, Gloria Sierra, Sita Nookala, Ananta Yanamandra, Madison O’Hara, Jagannadha K Sastry
Publikováno v:
The Journal of Immunology. 206:29.11-29.11
High-risk type human papillomaviruses (HPV) are the underlying cause of >5% of all cancers including cervical and Head & Neck cancers in which virus-encoded E6/E7 oncoproteins serve as tumor-specific antigens. Despite the success of prophylactic HPV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::420b2daf59552b7453170350370cabfe
https://doi.org/10.4049/jimmunol.206.supp.29.11
https://doi.org/10.4049/jimmunol.206.supp.29.11